This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Solar urticaria

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Solar urticaria has an equal incidence in males and females.

Onset may be sudden and may be life-threatening. It is induced by exposure to UVA and visible light wavelengths.

Treatment options for solar urticaria include:

  • non-sedating antihistamines such as fexofenadine and cetirizine
  • other options include absorbent sunscreens, restriction of UVR at the relevant wavelength (it can be useful to photo-test patients to assess which wavelengths trigger their symptoms and how easily the urticaria is provoked (3)), maintenance of a non-responsive state with natural or artificial light exposure and immunosuppressive therapy e.g. plasmapheresis

Reference:

  1. Ferguson J.Photosensitivity disorders.Medicine International (1992);102:4282-4.
  2. Am J Clin Dermatol. 2002;3(4):239-46.
  3. Primary Care Dermatological Society. Solar urticaria (Accessed 30/7/14)

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.